1.
The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment.
2.
3.
Is there a role for dacomitinib, a second-generation irreversible inhibitor of the epidermal-growth factor receptor tyrosine kinase, in advanced non-small cell lung cancer?